These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 31142430

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models.
    Caldwell AS, Middleton LJ, Jimenez M, Desai R, McMahon AC, Allan CM, Handelsman DJ, Walters KA.
    Endocrinology; 2014 Aug; 155(8):3146-59. PubMed ID: 24877633
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Reproductive and metabolic phenotype of a mouse model of PCOS.
    van Houten EL, Kramer P, McLuskey A, Karels B, Themmen AP, Visser JA.
    Endocrinology; 2012 Jun; 153(6):2861-9. PubMed ID: 22334715
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Haplosufficient genomic androgen receptor signaling is adequate to protect female mice from induction of polycystic ovary syndrome features by prenatal hyperandrogenization.
    Caldwell AS, Eid S, Kay CR, Jimenez M, McMahon AC, Desai R, Allan CM, Smith JT, Handelsman DJ, Walters KA.
    Endocrinology; 2015 Apr; 156(4):1441-52. PubMed ID: 25643156
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Polycystic ovary syndrome: possible involvement of androgen-induced, chemerin-mediated ovarian recruitment of monocytes/macrophages.
    Lima PDA, Nivet AL, Wang Q, Chen YA, Leader A, Cheung A, Tzeng CR, Tsang BK.
    Biol Reprod; 2018 Oct 01; 99(4):838-852. PubMed ID: 29688269
    [Abstract] [Full Text] [Related]

  • 11. Androgen Action in Adipose Tissue and the Brain are Key Mediators in the Development of PCOS Traits in a Mouse Model.
    Cox MJ, Edwards MC, Rodriguez Paris V, Aflatounian A, Ledger WL, Gilchrist RB, Padmanabhan V, Handelsman DJ, Walters KA.
    Endocrinology; 2020 Jul 01; 161(7):. PubMed ID: 32301482
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pigment epithelium-derived factor (PEDF) negates hyperandrogenic PCOS features.
    Miller I, Bar-Joseph H, Nemerovsky L, Ben-Ami I, Shalgi R.
    J Endocrinol; 2020 May 01; 245(2):291-300. PubMed ID: 32171180
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Comparison of Reproductive Function Between Normal and Hyperandrogenemia Conditions in Female Mice With Deletion of Hepatic Androgen Receptor.
    Feng M, Divall S, Jones D, Ubba V, Fu X, Yang L, Wang H, Yang X, Wu S.
    Front Endocrinol (Lausanne); 2022 May 01; 13():868572. PubMed ID: 35757434
    [Abstract] [Full Text] [Related]

  • 18. Insulin signaling displayed a differential tissue-specific response to low-dose dihydrotestosterone in female mice.
    Andrisse S, Billings K, Xue P, Wu S.
    Am J Physiol Endocrinol Metab; 2018 Apr 01; 314(4):E353-E365. PubMed ID: 29351485
    [Abstract] [Full Text] [Related]

  • 19. Troxerutin attenuates insulin resistance via pancreatic IL-22/JAK1/STAT3 signaling activation in dihydrotestosterone-induced polycystic ovary syndrome rats.
    Gao Z, Wang G, Ma X, Tan H, Zhang C, Yin X, Suo F, Yao R, Yan X.
    Am J Physiol Endocrinol Metab; 2022 Nov 01; 323(5):E405-E417. PubMed ID: 36103628
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.